Sattya Narayan Talukdar

Dr. Sattya Narayan Talukdar

University of North Dakota
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
STSattya Narayan Talukdar
Sattya Narayan Talukdar
MHMohammad Nazir Hossain
Mohammad Nazir Hossain
Momordica dioica is a perennial, dioecious, cucurbitaceous climbing creeper (commonly known as kakrol, spiny gourd or teasle gourd). It is native to Asia with extensive distribution in India and Bangladesh. It is used not only as preventive and curative agent for various diseases but also as vegetable with a significant nutritional value over thousands of years. This review aims to take an attempt to evaluate the phytochemical, ethnobotanical, phytotherapeutical and pharmacological properties of kakrol according to the view of traditional medicinal plant based treatment including ayurveda along with recent scientific observations. Kakrol is considered as an underutilized vegetable, although having significant presence of certain compounds containing higher nutritional value than many frequently consumed vegetables. Moreover, as a traditional medicinal plant, it is still potential for its phytochemical components that increase the demand of further extensive evaluation to justify its other therapeutical roles. Therefore, this effort will be helpful to researchers who interested to disclose the unjustified phytotherapeutical role of Momordica dioica.

26 December 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
APAutumn Paluck
Autumn Paluck
JOJaspreet Kaur Osan
Jaspreet Kaur Osan
LHLauren Hollingsworth
Lauren Hollingsworth
STSattya Narayan Talukdar
Sattya Narayan Talukdar
ASAli Al Saegh
Ali Al Saegh
Masfique MehediMasfique Mehedi
Masfique Mehedi
Respiratory syncytial virus (RSV) is the leading viral agent causing bronchiolitis and pneumonia in children under five years old worldwide. The RSV infection cycle starts with macropinocytosis-based entry into the host airway epithelial cell membrane, followed by virus transcription, replication, assembly, budding, and spread. It is not surprising that the host actin cytoskeleton contributes to different stages of the RSV replication cycle. RSV modulates actin-related protein 2/3 (ARP2/3) complex-driven actin polymerization for a robust filopodia induction on the infected lung epithelial A549 cells, which contributes to the virus’s budding, and cell-to-cell spread. Thus, a comprehensive understanding of RSV-induced cytoskeletal modulation and its role in lung pathobiology may identify novel intervention strategies. This review will focus on the role of the ARP2/3 complex in RSV’s pathogenesis and possible therapeutic targets to the ARP2/3 complex for RSV.

1 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
SCSabal Chaulagain
Sabal Chaulagain
AWAnnie Werner
Annie Werner
MPMaclaine A. Parish
Maclaine A. Parish
STSattya Narayan Talukdar
Sattya Narayan Talukdar
BSBrittany A. Seibert
Brittany A. Seibert
SKSabra Klein
Sabra Klein
H5N1 vaccines have been poorly immunogenic in humans, creating a challenge for vaccine development. Seasonal influenza vaccines offer some cross-protection against H5N1, but there has been no consideration of whether protection differs between the sexes. We investigated antibody responses and protection in adult male and female C57BL/6 mice following vaccination with either beta-propiolactone inactivated whole virus H1N1 or H5N1 (LAIV backbone) vaccines. Using systems serology assays, we uncovered that vaccination induced strong homologous antibody responses, with females generating greater total IgG than males against both H1N1 and H5N1, which was primarily mediated by greater IgG responses to neuraminidase (NA) than hemagglutinin (HA) protein. Cross-reactive H1N1 IgG titers were greater among H5N1-vaccinated females, primarily mediated by greater N1-specific IgG titers. IgG2b and IgG2c were the primary antibody isotypes generated in response to these vaccines, with females having greater IgG2b titers and enhanced binding to FcγRIV for avian and human NA than males following either homologous or heterologous vaccination. Antibody-dependent complement deposition was measured as an FcR-mediated non-neutralizing response against HA and NA and was robust in both sexes. Vaccinated females had greater neutralizing antibody titers than males against the homologous vaccine strain, with limited cross-neutralizing antibodies detected in either sexes. Neuraminidase inhibition titers were greater in vaccinated females than males against the heterologous virus following H1N1 vaccination and against both the vaccine and heterologous viruses following H5N1 vaccination. When H1N1 and H5N1 vaccinated mice were challenged with a lethal dose of A/Texas/37/2024 H5N1, all H5N1 vaccinated mice were protected, regardless of sex. Among H1N1 vaccinated mice, while both sexes were protected against disease, H1N1 vaccinated females cleared virus faster than their male counterparts. These findings highlight that female-biased NA-specific antibodies result in greater cross-protection and should be considered in studies of influenza vaccines.

29 May 2026 in bioRxiv
Verified
Preprint
Open access
SCSabal Chaulagain
Sabal Chaulagain
AWAnnie Werner
Annie Werner
MPMaclaine A. Parish
Maclaine A. Parish
STSattya Narayan Talukdar
Sattya Narayan Talukdar
BSBrittany A. Seibert
Brittany A. Seibert
SKSabra L. Klein
Sabra L. Klein
H5N1 vaccines have been poorly immunogenic in humans, creating a challenge for vaccine development. Seasonal influenza vaccines offer some cross-protection against H5N1, but there has been no consideration of whether protection differs between the sexes. We investigated antibody responses and protection in adult male and female C57BL/6 mice following vaccination with either beta-propiolactone inactivated whole virus H1N1 or H5N1 (LAIV backbone) vaccines. Using systems serology assays, we uncovered that vaccination induced strong homologous antibody responses, with females generating greater total IgG than males against both H1N1 and H5N1, which was primarily mediated by greater IgG responses to neuraminidase (NA) than hemagglutinin (HA) protein. Cross-reactive H1N1 IgG titers were greater among H5N1-vaccinated females, primarily mediated by greater N1-specific IgG titers. IgG2b and IgG2c were the primary antibody isotypes generated in response to these vaccines, with females having greater IgG2b titers and enhanced binding to FcγRIV for avian and human NA than males following either homologous or heterologous vaccination. Antibody-dependent complement deposition was measured as an FcR-mediated non-neutralizing response against HA and NA and was robust in both sexes. Vaccinated females had greater neutralizing antibody titers than males against the homologous vaccine strain, with limited cross-neutralizing antibodies detected in either sexes. Neuraminidase inhibition titers were greater in vaccinated females than males against the heterologous virus following H1N1 vaccination and against both the vaccine and heterologous viruses following H5N1 vaccination. When H1N1 and H5N1 vaccinated mice were challenged with a lethal dose of A/Texas/37/2024 H5N1, all H5N1 vaccinated mice were protected, regardless of sex. Among H1N1 vaccinated mice, while both sexes were protected against disease, H1N1 vaccinated females cleared virus faster than their male counterparts. These findings highlight that female-biased NA-specific antibodies result in greater cross-protection and should be considered in studies of influenza vaccines. Highlights: Females mount stronger IgG responses than males to both H1N1 and H5N1 vaccines Sex differences in vaccine responses are driven by immunity to neuraminidase (NA) Females mount stronger anti-NA IgG2b responses with greater binding to FcγRIV than males NA inhibition titers are greater in females, supporting broader cross-protection H1N1-vaccinated females clear H5N1virus faster than males after lethal challenge